874981.fig.001a
(a)
874981.fig.001b
(b)
Figure 1: Ultraperformance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UPLC-Q-TOF MS) profiles of sera from human subjects who were controlled by BSPs before and after 12 weeks of intervention.